Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-5-31
pubmed:abstractText
Endotoxin or lipopolysaccharide (LPS) tolerance may be partially due to the secretion of potent anti-inflammatory cytokines following severe Gram-negative infections, or by low doses of LPS. In this work, we describe the effects of interleukin-1 (IL-1) and tumour necrosis factor alpha (TNF-), two early cytokines secreted after LPS exposure, in the induction of LPS tolerance. Our results demonstrate that mice treated with three daily doses of 100 ng of IL-1 were tolerant to LPS-induced shock. However, TNF- was unable to induce an LPS refractory state. Given the fact that 100 ng of IL-1 increase the plasma levels of glucocorticoids, we evaluated whether a daily injection of dexamethasone (DEX) alone was able to reproduce the LPS-like tolerant state. However, no signs of LPS refractoriness were detected, except when DEX was administered concomitantly with a dose of IL-1 that does not induce corticosterone secretion (12 ng/mouse). This dose was found to induce in vitro up-regulation of the glucocorticoid receptors (GcR) of peritoneal macrophages following 24 h of treatment. In addition, we demonstrate that IL-1 is capable of inducing the down-regulation of Toll-like receptor 4 (TLR4), a crucial molecule in the signal transduction of LPS. Taken together, our results indicate that IL-1 can generate tolerance to LPS in vivo, and suggest that the regulation of mechanisms of the down-regulation of TLR4, as well as those involved in the expression of GcR and/or in the secretion of glucocorticoids, would be crucial for these effects.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-10215628, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-10340167, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-10340175, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-10435584, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-10725698, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-10725699, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-10820230, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-1311550, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-1315358, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-1360996, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-1484316, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-1716205, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-2842396, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-2842660, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-3294337, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-3856324, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-4902894, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-6287580, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-6546969, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-7421206, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-7561052, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-7722463, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-8479467, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-8630372, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-8674323, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-9058827, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-9058829, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-9103466, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-9176497, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-9237746, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-9625770, http://linkedlifedata.com/resource/pubmed/commentcorrection/12041508-9734363
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone, http://linkedlifedata.com/resource/pubmed/chemical/Drosophila Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1, http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Glucocorticoid, http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptor 4, http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptors, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
128
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
221-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:12041508-Animals, pubmed-meshheading:12041508-Anti-Inflammatory Agents, pubmed-meshheading:12041508-Dexamethasone, pubmed-meshheading:12041508-Down-Regulation, pubmed-meshheading:12041508-Drosophila Proteins, pubmed-meshheading:12041508-Gram-Negative Bacterial Infections, pubmed-meshheading:12041508-Immune Tolerance, pubmed-meshheading:12041508-Interleukin-1, pubmed-meshheading:12041508-Lipopolysaccharides, pubmed-meshheading:12041508-Membrane Glycoproteins, pubmed-meshheading:12041508-Mice, pubmed-meshheading:12041508-Mice, Inbred BALB C, pubmed-meshheading:12041508-Receptors, Cell Surface, pubmed-meshheading:12041508-Receptors, Glucocorticoid, pubmed-meshheading:12041508-Toll-Like Receptor 4, pubmed-meshheading:12041508-Toll-Like Receptors, pubmed-meshheading:12041508-Tumor Necrosis Factor-alpha, pubmed-meshheading:12041508-Up-Regulation
pubmed:year
2002
pubmed:articleTitle
Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice.
pubmed:affiliation
División Immunología, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina. ferar@ciudad.com.ar
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't